{
  "ticker": "JNJ",
  "key": "JNJ_Q2_2025",
  "year": 2025,
  "quarter": 2,
  "verified_at": "2026-02-13T12:10:17.507323",
  "claims_with_verdicts": [
    {
      "claim": {
        "gaap_classification": "non_gaap",
        "claimed_value": 4.6,
        "is_approximate": false,
        "period": "Q2 2025",
        "metric_context": "Total",
        "speaker_role": "ceo",
        "metric_type": "revenue",
        "speaker": "Joaquin Duato",
        "claim_type": "yoy_growth",
        "quote_end_char": 1069,
        "claim_id": "claim_001",
        "comparison_period": "Q2 2024",
        "qualifiers": [
          "operational"
        ],
        "claimed_value_raw": "4.6%",
        "confidence": 1,
        "scale": null,
        "quote_start_char": 1001,
        "quote_text": "In the second quarter, we delivered operational sales growth of 4.6%",
        "unit": "percent"
      },
      "verification": {
        "claim_id": "claim_001",
        "claimed_value": 4.6,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "unit": "percent",
        "claimed_value_raw": "3.8%",
        "claim_id": "claim_002",
        "quote_start_char": 1091,
        "scale": null,
        "quote_end_char": 1156,
        "quote_text": "In innovative medicine, we reported 3.8% operational sales growth",
        "comparison_period": "Q2 2024",
        "metric_type": "revenue",
        "is_approximate": false,
        "metric_context": "Innovative Medicine",
        "claimed_value": 3.8,
        "confidence": 1,
        "speaker": "Joaquin Duato",
        "period": "Q2 2025",
        "claim_type": "yoy_growth",
        "qualifiers": [
          "operational"
        ],
        "gaap_classification": "non_gaap",
        "speaker_role": "ceo"
      },
      "verification": {
        "claim_id": "claim_002",
        "claimed_value": 3.8,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "metric_context": "Innovative Medicine",
        "qualifiers": [
          "more than",
          "record",
          "first time"
        ],
        "claim_id": "claim_003",
        "comparison_period": null,
        "metric_type": "revenue",
        "quote_end_char": 1229,
        "quote_start_char": 1158,
        "gaap_classification": "gaap",
        "speaker_role": "ceo",
        "claimed_value": 15,
        "unit": "dollars",
        "claimed_value_raw": "$15 billion",
        "claim_type": "absolute",
        "speaker": "Joaquin Duato",
        "quote_text": "delivering more than $15 billion in quarterly sales for the first time.",
        "period": "Q2 2025",
        "scale": "billions",
        "confidence": 1,
        "is_approximate": false
      },
      "verification": {
        "claim_id": "claim_003",
        "claimed_value": 15,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "segment_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This is a Innovative Medicine revenue claim. Our data only includes total company-level figures.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "comparison_period": "Q2 2024",
        "quote_text": "Delivering 6.1% operational sales growth",
        "quote_end_char": 1667,
        "claimed_value": 6.1,
        "claimed_value_raw": "6.1%",
        "quote_start_char": 1627,
        "period": "Q2 2025",
        "speaker": "Joaquin Duato",
        "gaap_classification": "non_gaap",
        "claim_id": "claim_004",
        "speaker_role": "ceo",
        "unit": "percent",
        "claim_type": "yoy_growth",
        "metric_context": "MedTech",
        "scale": null,
        "metric_type": "revenue",
        "is_approximate": false,
        "qualifiers": [
          "operational"
        ],
        "confidence": 1
      },
      "verification": {
        "claim_id": "claim_004",
        "claimed_value": 6.1,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "quote_start_char": 1791,
        "quote_end_char": 1857,
        "is_approximate": false,
        "quote_text": "we are pleased to raise our full-year sales guidance by $2 billion",
        "period": "FY 2025",
        "metric_type": "revenue",
        "speaker": "Joaquin Duato",
        "claim_type": "guidance",
        "unit": "dollars",
        "metric_context": "Total",
        "claimed_value_raw": "$2 billion",
        "speaker_role": "ceo",
        "claim_id": "claim_005",
        "scale": "billions",
        "confidence": 1,
        "claimed_value": 2,
        "qualifiers": [
          "raise"
        ],
        "comparison_period": null,
        "gaap_classification": "gaap"
      },
      "verification": {
        "claim_id": "claim_005",
        "claimed_value": 2,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "guidance_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "Forward-looking guidance claims cannot be verified against historical data.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "claim_type": "guidance",
        "quote_start_char": 1858,
        "metric_context": "Total",
        "is_approximate": false,
        "speaker_role": "ceo",
        "period": "FY 2025",
        "gaap_classification": "non_gaap",
        "scale": null,
        "claim_id": "claim_006",
        "qualifiers": [
          "raise"
        ],
        "quote_end_char": 1883,
        "quote_text": "and EPS guidance by $0.25",
        "speaker": "Joaquin Duato",
        "confidence": 1,
        "comparison_period": null,
        "metric_type": "eps_diluted",
        "claimed_value_raw": "$0.25",
        "claimed_value": 0.25,
        "unit": "per_share"
      },
      "verification": {
        "claim_id": "claim_006",
        "claimed_value": 0.25,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "quote_text": "10.60",
        "claimed_value": 10.6,
        "unit": "per_share",
        "quote_start_char": 1890,
        "confidence": 1,
        "comparison_period": null,
        "claim_id": "claim_007",
        "speaker_role": "ceo",
        "quote_end_char": 1895,
        "metric_type": "eps_diluted",
        "gaap_classification": "non_gaap",
        "claimed_value_raw": "$10.60",
        "claim_type": "guidance",
        "scale": null,
        "qualifiers": [],
        "speaker": "Joaquin Duato",
        "metric_context": "Total",
        "is_approximate": false,
        "period": "FY 2025"
      },
      "verification": {
        "claim_id": "claim_007",
        "claimed_value": 10.6,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "speaker_role": "ceo",
        "quote_text": "10.85.",
        "metric_type": "eps_diluted",
        "claimed_value_raw": "$10.85",
        "scale": null,
        "comparison_period": null,
        "speaker": "Joaquin Duato",
        "unit": "per_share",
        "period": "FY 2025",
        "gaap_classification": "non_gaap",
        "quote_end_char": 1906,
        "metric_context": "Total",
        "quote_start_char": 1900,
        "qualifiers": [
          "to"
        ],
        "confidence": 1,
        "claim_id": "claim_008",
        "is_approximate": false,
        "claimed_value": 10.85,
        "claim_type": "guidance"
      },
      "verification": {
        "claim_id": "claim_008",
        "claimed_value": 10.85,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "metric_context": "Oncology",
        "speaker_role": "ceo",
        "scale": "billions",
        "gaap_classification": "gaap",
        "claim_id": "claim_009",
        "comparison_period": null,
        "speaker": "Joaquin Duato",
        "unit": "dollars",
        "claimed_value": 50,
        "quote_text": "we expect to become the number one oncology company by 2030 with sales of more than $50 billion.",
        "period": "FY 2030",
        "confidence": 1,
        "metric_type": "revenue",
        "is_approximate": false,
        "claimed_value_raw": "$50 billion",
        "quote_end_char": 3012,
        "claim_type": "guidance",
        "quote_start_char": 2916,
        "qualifiers": [
          "more than"
        ]
      },
      "verification": {
        "claim_id": "claim_009",
        "claimed_value": 50,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "guidance_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "Forward-looking guidance claims cannot be verified against historical data.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "qualifiers": [
          "operational"
        ],
        "period": "Q2 2025",
        "claim_id": "claim_010",
        "claimed_value_raw": "22.3%",
        "speaker_role": "ceo",
        "speaker": "Joaquin Duato",
        "metric_type": "revenue",
        "comparison_period": "Q2 2024",
        "quote_start_char": 3013,
        "metric_context": "Oncology",
        "quote_text": "And when you look at our quarterly results in oncology, with operational sales growth of 22.3%",
        "claimed_value": 22.3,
        "claim_type": "yoy_growth",
        "quote_end_char": 3107,
        "confidence": 1,
        "gaap_classification": "non_gaap",
        "scale": null,
        "unit": "percent",
        "is_approximate": false
      },
      "verification": {
        "claim_id": "claim_010",
        "claimed_value": 22.3,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "speaker": "Joaquin Duato",
        "gaap_classification": "gaap",
        "claim_type": "guidance",
        "confidence": 1,
        "comparison_period": null,
        "qualifiers": [
          "peak year",
          "at least",
          "annual"
        ],
        "claimed_value_raw": "$5 billion",
        "speaker_role": "ceo",
        "quote_start_char": 4724,
        "period": "Peak Year",
        "metric_type": "revenue",
        "unit": "dollars",
        "quote_text": "We expect TAR-200 to generate at least $5 billion in annual peak year sales.",
        "scale": "billions",
        "quote_end_char": 4800,
        "is_approximate": false,
        "claimed_value": 5,
        "metric_context": "TAR-200",
        "claim_id": "claim_011"
      },
      "verification": {
        "claim_id": "claim_011",
        "claimed_value": 5,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "guidance_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "Forward-looking guidance claims cannot be verified against historical data.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "unit": "percent",
        "claimed_value_raw": "30%",
        "qualifiers": [],
        "scale": null,
        "quote_text": "TREMFYA grew 30% in the quarter.",
        "claimed_value": 30,
        "metric_type": "revenue",
        "metric_context": "TREMFYA",
        "claim_id": "claim_012",
        "quote_start_char": 5500,
        "claim_type": "yoy_growth",
        "comparison_period": "Q2 2024",
        "confidence": 1,
        "quote_end_char": 5532,
        "is_approximate": false,
        "speaker_role": "ceo",
        "speaker": "Joaquin Duato",
        "period": "Q2 2025",
        "gaap_classification": "gaap"
      },
      "verification": {
        "claim_id": "claim_012",
        "claimed_value": 30,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "segment_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This is a TREMFYA revenue growth claim. Our data only includes total company-level figures.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "metric_type": "revenue",
        "metric_context": "TREMFYA",
        "speaker_role": "ceo",
        "quote_text": "we expect TREMFYA to generate at least $10 billion annually in peak year sales.",
        "qualifiers": [
          "at least",
          "annually"
        ],
        "claim_id": "claim_013",
        "scale": "billions",
        "comparison_period": null,
        "unit": "dollars",
        "claimed_value_raw": "$10 billion",
        "speaker": "Joaquin Duato",
        "period": "Peak Year",
        "confidence": 1,
        "is_approximate": false,
        "quote_end_char": 5674,
        "quote_start_char": 5595,
        "claim_type": "guidance",
        "claimed_value": 10,
        "gaap_classification": "gaap"
      },
      "verification": {
        "claim_id": "claim_013",
        "claimed_value": 10,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "guidance_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "Forward-looking guidance claims cannot be verified against historical data.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "unit": "percent",
        "metric_context": "SPRAVATO",
        "comparison_period": "Q2 2024",
        "claim_type": "yoy_growth",
        "period": "Q2 2025",
        "confidence": 1,
        "metric_type": "revenue",
        "claimed_value": 53,
        "claim_id": "claim_014",
        "is_approximate": false,
        "scale": null,
        "gaap_classification": "gaap",
        "speaker": "Joaquin Duato",
        "claimed_value_raw": "53%",
        "quote_end_char": 6364,
        "speaker_role": "ceo",
        "qualifiers": [],
        "quote_start_char": 6340,
        "quote_text": "In Q2, SPRAVATO grew 53%"
      },
      "verification": {
        "claim_id": "claim_014",
        "claimed_value": 53,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "segment_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This is a SPRAVATO revenue growth claim. Our data only includes total company-level figures.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "claim_type": "guidance",
        "claimed_value_raw": "$5 billion-plus",
        "is_approximate": false,
        "confidence": 1,
        "gaap_classification": "gaap",
        "speaker_role": "ceo",
        "period": "Peak Year",
        "metric_type": "revenue",
        "quote_start_char": 6934,
        "metric_context": "CAPLYTA",
        "scale": "billions",
        "claimed_value": 5,
        "quote_end_char": 7046,
        "quote_text": "CAPLYTA adds to Johnson & Johnson's robust lineup of therapies with $5 billion-plus potential in peak year sales",
        "speaker": "Joaquin Duato",
        "unit": "dollars",
        "claim_id": "claim_015",
        "comparison_period": null,
        "qualifiers": [
          "potential"
        ]
      },
      "verification": {
        "claim_id": "claim_015",
        "claimed_value": 5,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "guidance_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "Forward-looking guidance claims cannot be verified against historical data.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "quote_start_char": 7398,
        "scale": null,
        "claimed_value_raw": "22%",
        "claim_type": "yoy_growth",
        "speaker": "Joaquin Duato",
        "metric_type": "revenue",
        "qualifiers": [
          "operational",
          "over"
        ],
        "confidence": 1,
        "speaker_role": "ceo",
        "quote_text": "In Q2, we delivered over 22% operational sales growth over the quarter",
        "claimed_value": 22,
        "unit": "percent",
        "gaap_classification": "non_gaap",
        "comparison_period": "Q2 2024",
        "period": "Q2 2025",
        "metric_context": "Cardiovascular",
        "is_approximate": false,
        "quote_end_char": 7468,
        "claim_id": "claim_016"
      },
      "verification": {
        "claim_id": "claim_016",
        "claimed_value": 22,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "qualifiers": [
          "operational",
          "close to"
        ],
        "quote_start_char": 7808,
        "claim_type": "yoy_growth",
        "quote_end_char": 7906,
        "speaker_role": "ceo",
        "quote_text": "First is electrophysiology, which delivered close to 10% operational sales growth over the quarter",
        "claimed_value_raw": "10%",
        "confidence": 1,
        "claim_id": "claim_017",
        "gaap_classification": "non_gaap",
        "speaker": "Joaquin Duato",
        "is_approximate": true,
        "scale": null,
        "claimed_value": 10,
        "metric_type": "revenue",
        "metric_context": "Electrophysiology",
        "period": "Q2 2025",
        "comparison_period": "Q2 2024",
        "unit": "percent"
      },
      "verification": {
        "claim_id": "claim_017",
        "claimed_value": 10,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "metric_type": "revenue",
        "period": "FY 2025",
        "quote_start_char": 8711,
        "gaap_classification": "gaap",
        "claimed_value": 13,
        "claim_type": "guidance",
        "is_approximate": false,
        "confidence": 1,
        "claimed_value_raw": "$13 billion",
        "qualifiers": [],
        "comparison_period": null,
        "unit": "dollars",
        "claim_id": "claim_018",
        "speaker_role": "ceo",
        "metric_context": "Shockwave",
        "speaker": "Joaquin Duato",
        "scale": "billions",
        "quote_text": "Shockwave is expected to be our $13 billion MedTech platform by the end of the year",
        "quote_end_char": 8794
      },
      "verification": {
        "claim_id": "claim_018",
        "claimed_value": 13,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "guidance_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "Forward-looking guidance claims cannot be verified against historical data.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "quote_start_char": 10314,
        "claim_id": "claim_019",
        "unit": "percent",
        "quote_end_char": 10337,
        "claimed_value": 8.9,
        "speaker_role": "ceo",
        "is_approximate": false,
        "scale": null,
        "confidence": 1,
        "gaap_classification": "non_gaap",
        "comparison_period": "Q2 2024",
        "qualifiers": [],
        "metric_type": "revenue",
        "metric_context": "Surgical Vision",
        "claimed_value_raw": "8.9%",
        "speaker": "Joaquin Duato",
        "quote_text": "8.9% in Surgical Vision",
        "period": "Q2 2025",
        "claim_type": "yoy_growth"
      },
      "verification": {
        "claim_id": "claim_019",
        "claimed_value": 8.9,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "qualifiers": [],
        "gaap_classification": "gaap",
        "speaker": "Darren Snellgrove",
        "quote_text": "Worldwide sales were $23.7 billion for the quarter.",
        "metric_context": "Total",
        "is_approximate": false,
        "comparison_period": null,
        "scale": "billions",
        "claimed_value_raw": "$23.7 billion",
        "metric_type": "revenue",
        "speaker_role": "management",
        "quote_end_char": 11620,
        "quote_start_char": 11569,
        "claim_id": "claim_020",
        "claim_type": "absolute",
        "period": "Q2 2025",
        "unit": "dollars",
        "confidence": 1,
        "claimed_value": 23.7
      },
      "verification": {
        "claim_id": "claim_020",
        "claimed_value": 23.7,
        "actual_value": 23743000000,
        "difference": -43000000.0,
        "difference_pct": 0.1811060101924778,
        "tolerance_used": 0.005,
        "computation_detail": "Claimed 23,700,000,000.00 vs Actual 23,743,000,000.00. Diff: 0.18% (threshold: 0.5%)",
        "computation_steps": [
          {
            "step": "Absolute comparison",
            "formula": "|23,700,000,000.00 - 23,743,000,000.00| / |23,743,000,000.00|",
            "result": 0.0018110601019247778,
            "threshold": 0.005
          }
        ],
        "financial_facts_used": [
          {
            "field": "revenue",
            "fy": 2025,
            "fq": 2,
            "value": 23743000000
          }
        ],
        "evidence_source": "fmp",
        "flags": [],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "Verified: claimed 23,700,000,000.00 vs actual 23,743,000,000.00 from fmp.",
        "verdict": "verified"
      }
    },
    {
      "claim": {
        "unit": "percent",
        "is_approximate": false,
        "speaker_role": "management",
        "claim_type": "yoy_growth",
        "confidence": 1,
        "claim_id": "claim_021",
        "metric_type": "revenue",
        "quote_end_char": 11704,
        "comparison_period": "Q2 2024",
        "metric_context": "Total",
        "speaker": "Darren Snellgrove",
        "claimed_value": 4.6,
        "scale": null,
        "gaap_classification": "gaap",
        "period": "Q2 2025",
        "quote_text": "Sales increased 4.6% despite an approximate 710 basis point headwind from STELARRA.",
        "quote_start_char": 11621,
        "qualifiers": [],
        "claimed_value_raw": "4.6%"
      },
      "verification": {
        "claim_id": "claim_021",
        "claimed_value": 4.6,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "Missing data for period(s): Q2 2024",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "claimed_value": 7.8,
        "comparison_period": "Q2 2024",
        "quote_end_char": 11730,
        "speaker_role": "management",
        "metric_type": "revenue",
        "metric_context": "US",
        "quote_text": "Growth in the US was 7.8%",
        "claimed_value_raw": "7.8%",
        "speaker": "Darren Snellgrove",
        "claim_id": "claim_022",
        "is_approximate": false,
        "period": "Q2 2025",
        "qualifiers": [],
        "scale": null,
        "confidence": 1,
        "unit": "percent",
        "claim_type": "yoy_growth",
        "quote_start_char": 11705,
        "gaap_classification": "gaap"
      },
      "verification": {
        "claim_id": "claim_022",
        "claimed_value": 7.8,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "segment_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This is a US revenue growth claim. Our data only includes total company-level figures.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "is_approximate": false,
        "speaker": "Darren Snellgrove",
        "claim_id": "claim_023",
        "unit": "percent",
        "qualifiers": [],
        "speaker_role": "management",
        "quote_end_char": 11758,
        "metric_type": "revenue",
        "claimed_value_raw": "0.6%",
        "scale": null,
        "metric_context": "Outside of the US",
        "period": "Q2 2025",
        "comparison_period": "Q2 2024",
        "confidence": 1,
        "quote_start_char": 11731,
        "claimed_value": 0.6,
        "quote_text": "and 0.6% outside of the US.",
        "claim_type": "yoy_growth",
        "gaap_classification": "gaap"
      },
      "verification": {
        "claim_id": "claim_023",
        "claimed_value": 0.6,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "segment_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This is a Outside of the US revenue growth claim. Our data only includes total company-level figures.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "period": "Q2 2025",
        "comparison_period": null,
        "qualifiers": [],
        "quote_start_char": 11908,
        "claim_id": "claim_024",
        "unit": "dollars",
        "scale": "billions",
        "speaker_role": "management",
        "confidence": 1,
        "gaap_classification": "gaap",
        "metric_context": "Total",
        "claim_type": "absolute",
        "metric_type": "net_income",
        "quote_end_char": 11955,
        "claimed_value": 5.5,
        "claimed_value_raw": "$5.5 billion",
        "is_approximate": false,
        "quote_text": "For the quarter, net earnings were $5.5 billion",
        "speaker": "Darren Snellgrove"
      },
      "verification": {
        "claim_id": "claim_024",
        "claimed_value": 5.5,
        "actual_value": 5537000000,
        "difference": -37000000.0,
        "difference_pct": 0.6682318945277226,
        "tolerance_used": 0.01,
        "computation_detail": "Claimed 5,500,000,000.00 vs Actual 5,537,000,000.00. Diff: 0.67% (threshold: 1.0%)",
        "computation_steps": [
          {
            "step": "Absolute comparison",
            "formula": "|5,500,000,000.00 - 5,537,000,000.00| / |5,537,000,000.00|",
            "result": 0.006682318945277226,
            "threshold": 0.01
          }
        ],
        "financial_facts_used": [
          {
            "field": "net_income",
            "fy": 2025,
            "fq": 2,
            "value": 5537000000
          }
        ],
        "evidence_source": "fmp",
        "flags": [],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "Verified: claimed 5,500,000,000.00 vs actual 5,537,000,000.00 from fmp.",
        "verdict": "verified"
      }
    },
    {
      "claim": {
        "gaap_classification": "gaap",
        "confidence": 1,
        "qualifiers": [],
        "metric_context": "Total",
        "claim_id": "claim_025",
        "claimed_value_raw": "$2.29",
        "unit": "per_share",
        "period": "Q2 2025",
        "is_approximate": false,
        "quote_text": "with diluted earnings per share of $2.29",
        "claim_type": "absolute",
        "speaker_role": "management",
        "speaker": "Darren Snellgrove",
        "metric_type": "eps_diluted",
        "quote_end_char": 11996,
        "scale": null,
        "comparison_period": null,
        "quote_start_char": 11956,
        "claimed_value": 2.29
      },
      "verification": {
        "claim_id": "claim_025",
        "claimed_value": 2.29,
        "actual_value": 2.29,
        "difference": 0.0,
        "difference_pct": 0.0,
        "tolerance_used": 0.015,
        "computation_detail": "EPS: claimed $2.29 vs actual $2.29. Diff $0.000 within $0.015 tolerance.",
        "computation_steps": [
          {
            "step": "EPS absolute comparison",
            "formula": "|2.29 - 2.29| = 0.000",
            "result": 0.0,
            "threshold": 0.015
          }
        ],
        "financial_facts_used": [
          {
            "field": "eps_diluted",
            "fy": 2025,
            "fq": 2,
            "value": 2.29
          }
        ],
        "evidence_source": "fmp",
        "flags": [],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "Verified: claimed $2.29 matches actual $2.29.",
        "verdict": "verified"
      }
    },
    {
      "claim": {
        "qualifiers": [],
        "period": "Q2 2024",
        "quote_start_char": 11997,
        "comparison_period": null,
        "unit": "per_share",
        "claimed_value": 1.93,
        "claimed_value_raw": "$1.93",
        "claim_type": "absolute",
        "speaker_role": "management",
        "confidence": 1,
        "speaker": "Darren Snellgrove",
        "claim_id": "claim_026",
        "is_approximate": false,
        "gaap_classification": "gaap",
        "metric_type": "eps_diluted",
        "metric_context": "Total",
        "quote_text": "versus diluted earnings per share of $1.93 a year ago.",
        "scale": null,
        "quote_end_char": 12051
      },
      "verification": {
        "claim_id": "claim_026",
        "claimed_value": 1.93,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "No eps_diluted data found for JNJ Q2 2024.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "metric_context": "Total",
        "quote_end_char": 12108,
        "quote_start_char": 12053,
        "qualifiers": [
          "adjusted"
        ],
        "period": "Q2 2025",
        "is_approximate": false,
        "speaker_role": "management",
        "quote_text": "Adjusted net earnings for the quarter were $6.7 billion",
        "scale": "billions",
        "metric_type": "net_income",
        "claimed_value": 6.7,
        "confidence": 1,
        "comparison_period": null,
        "claimed_value_raw": "$6.7 billion",
        "speaker": "Darren Snellgrove",
        "claim_type": "absolute",
        "gaap_classification": "non_gaap",
        "unit": "dollars",
        "claim_id": "claim_027"
      },
      "verification": {
        "claim_id": "claim_027",
        "claimed_value": 6.7,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "claim_type": "absolute",
        "quote_text": "with adjusted diluted earnings per share of $2.77",
        "metric_type": "eps_diluted",
        "comparison_period": null,
        "claimed_value_raw": "$2.77",
        "quote_end_char": 12158,
        "scale": null,
        "confidence": 1,
        "gaap_classification": "non_gaap",
        "unit": "per_share",
        "speaker": "Darren Snellgrove, speaker_role: management",
        "quote_start_char": 12109,
        "qualifiers": [
          "adjusted"
        ],
        "claimed_value": 2.77,
        "period": "Q2 2025",
        "claim_id": "claim_028",
        "metric_context": "Total",
        "is_approximate": false
      },
      "verification": {
        "claim_id": "claim_028",
        "claimed_value": 2.77,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "comparison_period": "Q2 2024",
        "confidence": 1,
        "metric_type": "eps_diluted",
        "claim_id": "claim_029",
        "quote_start_char": 12192,
        "claim_type": "yoy_growth",
        "metric_context": "Total (Adjusted EPS)",
        "qualifiers": [
          "decrease"
        ],
        "is_approximate": false,
        "speaker": "Darren Snellgrove",
        "speaker_role": "management",
        "quote_end_char": 12254,
        "unit": "percent",
        "gaap_classification": "non_gaap",
        "claimed_value_raw": "1.8%",
        "claimed_value": 1.8,
        "quote_text": "and 1.8% respectively, compared to the second quarter of 2024.",
        "period": "Q2 2025",
        "scale": null
      },
      "verification": {
        "claim_id": "claim_029",
        "claimed_value": 1.8,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "speaker": "Darren Snellgrove",
        "claim_type": "absolute",
        "claim_id": "claim_030",
        "quote_start_char": 12693,
        "quote_text": "Worldwide sales of $15.2 billion increased 3.8% despite an approximate 1170 basis point headwind from STELARRA",
        "speaker_role": "management",
        "comparison_period": null,
        "quote_end_char": 12803,
        "gaap_classification": "gaap",
        "claimed_value_raw": "$15.2 billion",
        "metric_context": "Innovative Medicine",
        "scale": "billions",
        "claimed_value": 15.2,
        "metric_type": "revenue",
        "confidence": 1,
        "period": "Q2 2025",
        "is_approximate": false,
        "qualifiers": [],
        "unit": "dollars"
      },
      "verification": {
        "claim_id": "claim_030",
        "claimed_value": 15.2,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "segment_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This is a Innovative Medicine revenue claim. Our data only includes total company-level figures.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "is_approximate": false,
        "scale": null,
        "claim_id": "claim_031",
        "speaker": "Darren Snellgrove",
        "claimed_value": 21.5,
        "speaker_role": "management",
        "qualifiers": [],
        "quote_end_char": 13219,
        "metric_context": "DARZALEX",
        "quote_text": "DARZALEX growth was 21.5%",
        "quote_start_char": 13194,
        "unit": "percent",
        "claim_type": "yoy_growth",
        "claimed_value_raw": "21.5%",
        "confidence": 1,
        "gaap_classification": "gaap",
        "period": "Q2 2025",
        "comparison_period": "Q2 2024",
        "metric_type": "revenue"
      },
      "verification": {
        "claim_id": "claim_031",
        "claimed_value": 21.5,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "segment_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This is a DARZALEX revenue growth claim. Our data only includes total company-level figures.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "unit": "dollars",
        "claimed_value_raw": "$439 million",
        "quote_start_char": 13402,
        "period": "Q2 2025",
        "scale": "millions",
        "speaker": "Darren Snellgrove",
        "metric_type": "revenue",
        "comparison_period": null,
        "claim_id": "claim_032",
        "speaker_role": "management",
        "claimed_value": 439,
        "quote_text": "CARVICTI achieved sales of $439 million with growth of over 100%",
        "qualifiers": [],
        "metric_context": "CARVICTI",
        "confidence": 1,
        "claim_type": "absolute",
        "quote_end_char": 13466,
        "is_approximate": false,
        "gaap_classification": "gaap"
      },
      "verification": {
        "claim_id": "claim_032",
        "claimed_value": 439,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "segment_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This is a CARVICTI revenue claim. Our data only includes total company-level figures.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "period": "Q2 2025",
        "metric_type": "revenue",
        "claim_id": "claim_033,claim_type: qoq_growth",
        "qualifiers": [
          "sequential growth"
        ],
        "is_approximate": false,
        "speaker_role": "management",
        "quote_text": "This reflects continued strong sequential growth of 17.9%",
        "claim_type": "qoq_growth",
        "comparison_period": "Q1 2025",
        "confidence": 1,
        "unit": "percent",
        "metric_context": "CARVICTI",
        "quote_end_char": 13571,
        "gaap_classification": "gaap",
        "claimed_value_raw": "17.9%",
        "scale": null,
        "speaker": "Darren Snellgrove",
        "quote_start_char": 13514,
        "claimed_value": 17.9
      },
      "verification": {
        "claim_id": "claim_033,claim_type: qoq_growth",
        "claimed_value": 17.9,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "segment_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This is a CARVICTI revenue growth claim. Our data only includes total company-level figures.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "qualifiers": [],
        "quote_text": "RYBREVANT plus LUMAKRAS delivered sales of $179 million and growth over 100%",
        "period": "Q2 2025",
        "claim_type": "absolute",
        "comparison_period": null,
        "gaap_classification": "gaap",
        "claimed_value": 179,
        "speaker_role": "management",
        "is_approximate": false,
        "quote_start_char": 13934,
        "quote_end_char": 14010,
        "metric_type": "revenue",
        "claimed_value_raw": "$179 million",
        "unit": "dollars",
        "scale": "millions",
        "claim_id": "claim_034",
        "confidence": 1,
        "metric_context": "RYBREVANT plus LUMAKRAS",
        "speaker": "Darren Snellgrove"
      },
      "verification": {
        "claim_id": "claim_034",
        "claimed_value": 179,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "segment_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This is a RYBREVANT plus LUMAKRAS revenue claim. Our data only includes total company-level figures.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "metric_context": "TREMFYA",
        "speaker": "Darren Snellgrove",
        "gaap_classification": "gaap",
        "claim_type": "yoy_growth",
        "scale": null,
        "claimed_value_raw": "30.1%",
        "claimed_value": 30.1,
        "confidence": 1,
        "qualifiers": [],
        "quote_text": "TREMFYA delivered growth of 30.1%",
        "quote_end_char": 14213,
        "speaker_role": "management",
        "period": "Q2 2025",
        "comparison_period": "Q2 2024",
        "unit": "percent",
        "claim_id": "claim_035",
        "metric_type": "revenue",
        "is_approximate": false,
        "quote_start_char": 14180
      },
      "verification": {
        "claim_id": "claim_035",
        "claimed_value": 30.1,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "segment_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This is a TREMFYA revenue growth claim. Our data only includes total company-level figures.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "qualifiers": [
          "declined by"
        ],
        "claim_type": "yoy_growth",
        "period": "Q2 2025",
        "quote_start_char": 14344,
        "claimed_value": 43.2,
        "speaker": "Darren Snellgrove",
        "is_approximate": false,
        "quote_end_char": 14370,
        "comparison_period": "Q2 2024",
        "confidence": 1,
        "metric_type": "revenue",
        "quote_text": "STELARRA declined by 43.2%",
        "claim_id": "claim_036",
        "unit": "percent",
        "speaker_role": "management",
        "metric_context": "STELARRA",
        "gaap_classification": "gaap",
        "claimed_value_raw": "43.2%",
        "scale": null
      },
      "verification": {
        "claim_id": "claim_036",
        "claimed_value": 43.2,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "segment_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This is a STELARRA revenue growth claim. Our data only includes total company-level figures.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "quote_end_char": 14782,
        "metric_context": "MedTech",
        "confidence": 1,
        "qualifiers": [],
        "speaker": "Darren Snellgrove",
        "gaap_classification": "gaap",
        "is_approximate": false,
        "scale": "billions",
        "comparison_period": null,
        "quote_start_char": 14736,
        "period": "Q2 2025",
        "claim_type": "absolute",
        "unit": "dollars",
        "claimed_value_raw": "$8.5 billion",
        "speaker_role": "management",
        "claimed_value": 8.5,
        "claim_id": "claim_037",
        "metric_type": "revenue",
        "quote_text": "Worldwide sales of $8.5 billion increased 6.1%"
      },
      "verification": {
        "claim_id": "claim_037",
        "claimed_value": 8.5,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "segment_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This is a MedTech revenue claim. Our data only includes total company-level figures.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "quote_text": "We continued our strong investment in research and development, with $3.5 billion or approximately 15% of sales in Q2.",
        "quote_start_char": 17006,
        "comparison_period": null,
        "speaker": "Darren Snellgrove",
        "speaker_role": "management",
        "is_approximate": false,
        "period": "Q2 2025",
        "scale": "billions",
        "claim_id": "claim_038",
        "unit": "dollars",
        "confidence": 1,
        "claim_type": "absolute",
        "gaap_classification": "gaap",
        "claimed_value": 3.5,
        "qualifiers": [],
        "quote_end_char": 17124,
        "claimed_value_raw": "$3.5 billion",
        "metric_context": "Total",
        "metric_type": "research_and_development"
      },
      "verification": {
        "claim_id": "claim_038",
        "claimed_value": 3.5,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "segment_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This is a Total research and development claim. Our data only includes total company-level figures.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "claimed_value_raw": "$6 billion",
        "period": "1H 2025",
        "is_approximate": false,
        "quote_start_char": 20271,
        "scale": "billions",
        "quote_end_char": 20336,
        "speaker": "John Reed",
        "gaap_classification": "unknown",
        "qualifiers": [
          "exceeded"
        ],
        "metric_type": "free_cash_flow",
        "unit": "dollars",
        "speaker_role": "management",
        "quote_text": "Free cash flow through the first half of 2025 exceeded $6 billion",
        "comparison_period": null,
        "claimed_value": 6,
        "confidence": 1,
        "claim_id": "claim_039",
        "claim_type": "absolute",
        "metric_context": "Total"
      },
      "verification": {
        "claim_id": "claim_039",
        "claimed_value": 6,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "ttm_or_multiperiod"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a trailing twelve-month (TTM), year-to-date, or multi-period figure. Our data contains single-quarter figures only.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "qualifiers": [
          "cash and marketable securities"
        ],
        "claim_type": "absolute",
        "metric_context": "Total",
        "is_approximate": false,
        "speaker_role": "management",
        "speaker": "John Reed",
        "quote_end_char": 20548,
        "quote_text": "We ended the second quarter with $19 billion of cash and marketable securities",
        "gaap_classification": "gaap",
        "unit": "dollars",
        "confidence": 1,
        "quote_start_char": 20470,
        "comparison_period": null,
        "period": "Q2 2025",
        "claimed_value_raw": "$19 billion",
        "metric_type": "other",
        "claim_id": "claim_040",
        "claimed_value": 19,
        "scale": "billions"
      },
      "verification": {
        "claim_id": "claim_040",
        "claimed_value": 19,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "Metric 'other' not in verification catalog.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "gaap_classification": "gaap",
        "unit": "dollars",
        "claimed_value": 51,
        "metric_context": "Total",
        "metric_type": "other",
        "quote_text": "and $51 billion of debt",
        "quote_start_char": 20549,
        "speaker": "John Reed",
        "period": "Q2 2025",
        "qualifiers": [
          "debt"
        ],
        "is_approximate": false,
        "confidence": 1,
        "claim_type": "absolute",
        "comparison_period": null,
        "claim_id": "claim_041",
        "quote_end_char": 20572,
        "speaker_role": "management",
        "scale": "billions",
        "claimed_value_raw": "$51 billion"
      },
      "verification": {
        "claim_id": "claim_041",
        "claimed_value": 51,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "Metric 'other' not in verification catalog.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "claim_type": "guidance",
        "claimed_value_raw": "$900 million",
        "claimed_value": 900,
        "speaker": "John Reed",
        "is_approximate": true,
        "quote_text": "we are increasing our operational sales guidance for the full year by approximately $900 million.",
        "confidence": 1,
        "unit": "dollars",
        "qualifiers": [
          "operational sales guidance",
          "increasing by approximately"
        ],
        "period": "FY 2025",
        "metric_context": "Total",
        "scale": "millions",
        "comparison_period": null,
        "quote_start_char": 21064,
        "claim_id": "claim_042",
        "gaap_classification": "non_gaap",
        "metric_type": "revenue",
        "quote_end_char": 21161,
        "speaker_role": "management"
      },
      "verification": {
        "claim_id": "claim_042",
        "claimed_value": 900,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "claim_id": "claim_043",
        "unit": "dollars",
        "period": "FY 2025",
        "qualifiers": [
          "midpoint",
          "operational"
        ],
        "speaker": "John Reed",
        "speaker_role": "management",
        "quote_text": "with a midpoint of $92.9 billion or 4.8% (operational sales growth)",
        "metric_context": "Total",
        "is_approximate": false,
        "claim_type": "guidance",
        "metric_type": "revenue",
        "comparison_period": null,
        "claimed_value_raw": "$92.9 billion",
        "quote_start_char": null,
        "gaap_classification": "non_gaap",
        "claimed_value": 92.9,
        "confidence": 1,
        "quote_end_char": null,
        "scale": "billions"
      },
      "verification": {
        "claim_id": "claim_043",
        "claimed_value": 92.9,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "non_gaap_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "This claim references a non-GAAP metric. Our data sources contain GAAP figures only. Non-GAAP metrics exclude items like stock-based compensation or restructuring charges.",
        "verdict": "unverifiable"
      }
    },
    {
      "claim": {
        "speaker_role": "management",
        "confidence": 1,
        "gaap_classification": "gaap",
        "period": "FY 2025",
        "quote_text": "with a midpoint of $93.4 billion or 5.4% (reported sales growth)",
        "scale": "billions",
        "quote_end_char": null,
        "claimed_value_raw": "$93.4 billion",
        "speaker": "John Reed",
        "claim_type": "guidance",
        "metric_context": "Total",
        "claimed_value": 93.4,
        "quote_start_char": null,
        "claim_id": "claim_044",
        "comparison_period": null,
        "metric_type": "revenue",
        "is_approximate": false,
        "unit": "dollars",
        "qualifiers": [
          "reported sales growth",
          "midpoint"
        ]
      },
      "verification": {
        "claim_id": "claim_044",
        "claimed_value": 93.4,
        "actual_value": null,
        "difference": null,
        "difference_pct": null,
        "tolerance_used": null,
        "computation_detail": null,
        "computation_steps": [],
        "financial_facts_used": [],
        "evidence_source": null,
        "flags": [
          "guidance_claim"
        ],
        "misleading_flags": [],
        "misleading_reasons": [],
        "explanation": "Forward-looking guidance claims cannot be verified against historical data.",
        "verdict": "unverifiable"
      }
    }
  ],
  "summary": {
    "total": 44,
    "verified": 3,
    "close_match": 0,
    "mismatch": 0,
    "misleading": 0,
    "unverifiable": 41
  }
}